Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schirner

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical & Experimental Metastasis|March 1, 1996
IL-4 and TNF-alpha induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cellsF Herzberg, M Schöning, M Schirner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cellsG Siemeister, M Schirner, P Reusch, et al.
The Journal of Biological Chemistry|February 20, 1999
Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGFC Piossek, J Schneider-Mergener, M Schirner, et al.
British Journal of Cancer|June 26, 2008
Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasisP Schulz, A Scholz, A Rexin, et al.
Hybridoma|December 5, 1997
Novel antibodies directed against the extracellular domain of the human VEGF-receptor type IIA Menrad, K H Thierauch, G Martiny-Baron, et al.
Cancer Research|July 9, 1999
Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathwayG Siemeister, M Schirner, K Weindel, et al.
The American Journal of Pathology|September 11, 2001
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanomaM Skobe, L M Hamberg, T Hawighorst, et al.
The Journal of Cell Biology|September 20, 2000
A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptorT Plath, K Detjen, M Welzel, et al.
Clinical & Experimental Metastasis|March 26, 1999
Integrin alpha5beta1: a potent inhibitor of experimental lung metastasisM Schirner, F Herzberg, R Schmidt, et al.
Neuroimage|May 21, 2005
Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ)M Reinhardt, P Hauff, R A Linker, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical & Experimental Metastasis|March 1, 1996
IL-4 and TNF-alpha induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cellsF Herzberg, M Schöning, M Schirner, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cellsG Siemeister, M Schirner, P Reusch, et al.
The Journal of Biological Chemistry|February 20, 1999
Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGFC Piossek, J Schneider-Mergener, M Schirner, et al.
British Journal of Cancer|June 26, 2008
Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasisP Schulz, A Scholz, A Rexin, et al.
Hybridoma|December 5, 1997
Novel antibodies directed against the extracellular domain of the human VEGF-receptor type IIA Menrad, K H Thierauch, G Martiny-Baron, et al.
Cancer Research|July 9, 1999
Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathwayG Siemeister, M Schirner, K Weindel, et al.
The American Journal of Pathology|September 11, 2001
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanomaM Skobe, L M Hamberg, T Hawighorst, et al.
The Journal of Cell Biology|September 20, 2000
A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptorT Plath, K Detjen, M Welzel, et al.
Clinical & Experimental Metastasis|March 26, 1999
Integrin alpha5beta1: a potent inhibitor of experimental lung metastasisM Schirner, F Herzberg, R Schmidt, et al.
Neuroimage|May 21, 2005
Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ)M Reinhardt, P Hauff, R A Linker, et al.
Pageof 4